Unterehmen auf Watchlist setzen
Bio-Techne
ISIN: US09073M1045
WKN: A12ENG
Curious about what AI knows about Bio-Techne? Just one click more
More AI Integrations
Über
Unternehmensprofil
Tipp: Investor-Alerts aktivieren
Lassen Sie sich bei neuen Publikationen informieren
Tipp: AI-Factsheet

Corporate News meets AI! 
Analyse der Inhalte und Zusammenfassung

Bio-Techne · ISIN: US09073M1045 · PR Newswire (ID: 20250415CG63950)
15 April 2025 01:00PM

Bio-Techne to Host Conference Call on May 7, 2025, to Announce Third Quarter Fiscal 2025 Financial Results


MINNEAPOLIS, April 15, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, May 7, 2025, at 8:00 a.m. CDT to review its third quarter fiscal 2025 financial results.

Access to the discussion may be obtained as follows:

Time:           

8:00 a.m. CDT

Date:                     

May 7, 2025

Dial-in:   

1-877-407-9208 or 1-201-493-6784 (for international callers)

Conference ID:     

13753150

Webcast:               

https://investors.bio-techne.com/ir-calendar

A recorded rebroadcast will be available for interested parties unable to participate in the live conference call by dialing 1-844-512-2921 or 1-412-317-6671 (for international callers) and referencing Conference ID 13753150.

The replay will be available from 11:00 a.m. CDT on Wednesday, May 7, 2025, until 11:00 p.m. CDT on Saturday, June 7, 2025.

About Bio-Techne

Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024 and has approximately 3,100 employees worldwide. For more information on Bio-Techne and its brands, please visit https://www.bio-techne.com or follow the Company on social media at: Facebook, LinkedIn, Twitter or YouTube.

Contact: 

David Clair, Vice President, Investor Relations & Corporate Development

david.clair@bio-techne.com

612-656-4416  

BT Logo (PRNewsfoto/Bio-Techne Corporation)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-host-conference-call-on-may-7-2025-to-announce-third-quarter-fiscal-2025-financial-results-302427650.html

SOURCE Bio-Techne Corporation

Visuelle Wertentwicklung / Kursverlauf · Bio-Techne
Smarte Analyse- und Recherchewerkzeuge finden Sie hier.
MIC: XNAS
This publication was provided by our content partner PR Newswire
PR Newswire
via PR Newswire - Newsfeed
Cision ©2025
PR Newswire
Kontakt:
300 S Riverside Plaza, Chicago, Illinois, USA
+001 (0) 888-776-0942